Manuela Morato, Dora Pinho, Teresa Sousa, Serafim Guimarães, Daniel Moura, António Albino-Teixeira
Index: Eur. J. Pharmacol. 531(1-3) , 209-16, (2006)
Full Text: HTML
Prejunctional facilitation of [3H]noradrenaline release induced by sympathetic nerve stimulation and postjunctional contractile effects of angiotensin II were studied in the mesenteric artery and vein of 1,3-dipropyl-8-sulfophenylxanthine (DPSPX)-hypertensive rats. Male Wistar rats received infusions of saline or DPSPX (90 microg/kg/h) i.p.. Blood pressure was determined by tail-cuff. The prejunctional effect of angiotensin II was similar in artery and vein preparations of control rats and was increased in DPSPX-hypertensive rats. In contrast, the contractile effect of angiotensin II was much more pronounced in the mesenteric vein than in the mesenteric artery of control rats and was markedly reduced in DPSPX-hypertensive rats. We conclude that (1) the increased prejunctional effect of angiotensin II may contribute to, while (2) the decreased contractile effect of angiotensin II may attenuate DPSPX-induced hypertension. This study also supports the hypothesis that pre- and postjunctional angiotensin II receptors are different.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
1,3-DIPROPYL-8-P-SULFOPHENYLXANTHINE
CAS:89073-57-4 |
C17H20N4O5S |
Extracellular 2',3'-cAMP-adenosine pathway in proximal tubul...
2013-01-01 [Am. J. Physiol. Renal Physiol. 304(1) , F49-55, (2013)] |
Expression of the 2',3'-cAMP-adenosine pathway in astrocytes...
2011-09-01 [J. Neurochem. 118 , 979-987, (2011)] |
Sustained reduction in myocardial reperfusion injury with an...
2000-03-01 [J. Pharmacol. Exp. Ther. 292(3) , 929-38, (2000)] |
Interaction of carbon monoxide and adenosine in the nucleus ...
2003-09-01 [Hypertension 42(3) , 380-5, (2003)] |
Angiotensin converting enzyme inhibition prevents trophic an...
2002-04-19 [Eur. J. Pharmacol. 441(1-2) , 99-104, (2002)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved